Peter F. Buckley, MD

Peter F. Buckley, MD

Posts by Author

Has any progress been made in our ability to manage negative symptoms of schizophrenia?

In schizophrenia therapy, the question arises whether a patient with hyper-religiosity as a main symptom can be treated with an antipsychotic (like clozapine) that targets that symptom.

What effect has the new antipsychotic Latuda had in patients with psychosis? Is a mood stabilizer as an adjunctive therapy necessary for schizophrenia or is the use of an antipsychotic alone sufficient?

Weight gain is a known side effect of some medications for schizophrenia. Here: strategies to prevent and manage weight gain.

In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.

Here: nutritional supplements and over-the counter medications in schizophrenia management.

In this video segment, Dr. Peter Buckley addresses 2 questions:
• What factors do you consider when you offer depot medications to a patient with schizophrenia?
• What can be done to encourage the use of depot medications?

In this video, international expert on schizophrenia, Peter F. Buckley, MD, gives an overview of what's new in schizophrenia and discusses the state-of-the-art of diagnosis and management of this complex and challenging disorder.

Does an early diagnosis of schizophrenia really make a clinical difference?

Project GREAT efforts in psychoeducation are geared toward educating providers about recovery so that they can, in turn, transform their own practices to be in concert with the recovery model.


By clicking Accept, you agree to become a member of the UBM Medica Community.